---
{"dg-publish":true,"permalink":"/entities/research/pmid-23471411-resveratrol-sirt-1-mechanism/","tags":["resveratrol","SIRT1","PGC-1alpha","mitochondrial biogenesis","caloric restriction","mechanism","longevity"]}
---


# SIRT1 activation by resveratrol: mechanism and physiological effects

## Study Information
**Authors**: Price NL, Gomes AP, Ling AJ, Duarte FV, Martin-Montalvo A, North BJ, Agarwal B, Ye L, Ramadori G, Teodoro JS, Hubbard BP, Varela AT, Davis JG, Varamini B, Hafber A, Moaddel R, Rolo AP, Coppari R, Palmeira CM, de Cabo R, Baur JA, Sinclair DA
**Journal**: Cell Metabolism
**Publication Date**: 2013-03-15
**Type**: Mechanistic Review
**Study Design**: Mechanistic Research (In Vivo/In Vitro)
**Evidence Level**: 2a
**Citations**: 1547
**DOI**: [10.1016/j.cmet.2013.02.011](https://doi.org/10.1016/j.cmet.2013.02.011)
**PMID**: [23471411](https://pubmed.ncbi.nlm.nih.gov/23471411/)
**PMC**: [PMC3545644](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3545644/)
**Semantic Scholar**: [View](https://www.semanticscholar.org/paper/PMID:23471411)

## Abstract
This comprehensive mechanistic review elucidates how resveratrol activates SIRT1 through allosteric modulation, triggering downstream effects on PGC-1alpha, mitochondrial biogenesis, and metabolic homeostasis. The paper provides critical evidence for resveratrol's role in mimicking caloric restriction benefits through the SIRT1/PGC-1alpha axis.

## Keywords
resveratrol, SIRT1, PGC-1alpha, mitochondrial biogenesis, caloric restriction, NAD+, sirtuins, aging

## Relationships
STUDIES::[[entities/Supplement/Resveratrol\|Resveratrol]] - Primary compound investigated
ACTIVATES::[[entities/protein/SIRT1\|SIRT1]] - Direct allosteric activation mechanism demonstrated
ACTIVATES::[[entities/protein/PGC-1alpha\|PGC-1alpha]] - Downstream target via SIRT1-mediated deacetylation
INCREASES::[[entities/Metabolite/NAD+\|NAD+]] - Required cofactor for SIRT1 activity
AFFECTS::[[entities/cellularcomponent/Mitochondria\|Mitochondria]] - Enhanced biogenesis and function
ACTIVATES::[[entities/protein/NRF2\|NRF2]] - Downstream transcription factor
ACTIVATES::[[entities/protein/TFAM\|TFAM]] - Mitochondrial transcription factor activation
RELATED_TO::[[entities/protein/AMPK\|AMPK]] - Cross-talk with energy sensing pathway
AFFECTS::[[entities/Organ/Muscle\|Muscle]] - Target tissue for metabolic effects
AFFECTS::[[entities/Organ/Liver\|Liver]] - Hepatic metabolic improvements

## Methodology
```yaml
design: Combined in vitro biochemistry, cell culture, and mouse models
models_used:
  - HEK293T cells
  - C2C12 myotubes
  - Primary hepatocytes
  - SIRT1 knockout mice
  - Diet-induced obese mice
techniques:
  - Fluorescent deacetylation assays
  - Western blotting
  - Metabolic cage analysis
  - Mitochondrial respiration (Seahorse)
  - Gene expression profiling
```

### Study Design
- **Duration**: Variable (acute to 15 weeks)
#### Population Characteristics
```yaml
in_vitro: Multiple cell lines including muscle and liver
in_vivo: C57BL/6J mice and SIRT1 knockout mice
dose_range: 10-400 mg/kg resveratrol (mouse studies)
```

## Results
### Key Findings
```yaml
primary:
  - name: SIRT1 activation mechanism
    result: Resveratrol binds SIRT1 N-terminus, requires specific substrate sequence
    finding: Activation is substrate-specific, not universal
  - name: PGC-1alpha deacetylation
    result: Resveratrol increases PGC-1alpha deacetylation via SIRT1
    p_value: <0.001
secondary:
  - name: Mitochondrial biogenesis markers
    result: Increased expression of NRF1, TFAM, cytochrome c
  - name: Oxygen consumption
    result: Enhanced mitochondrial respiration
  - name: Metabolic improvements
    result: Improved glucose tolerance in obese mice
```

### Statistical Analysis
#### Statistical Significance
```yaml
pgc1a_deacetylation: p < 0.001 vs vehicle
mitochondrial_content: p < 0.01 for mtDNA copy number
```
#### Effect Sizes
```yaml
sirt1_activity: 2-5 fold increase depending on substrate
mitochondrial_biogenesis: 30-50% increase in mitochondrial markers
```

## Limitations
- Mouse-to-human translation uncertain
- Bioavailability issues with oral resveratrol
- Substrate-specific activation complicates interpretation
- Some findings not replicated in human trials
- Dose-response relationships differ between species

## Research Integrity
### Funding Sources
- National Institute on Aging (NIH)
- Glenn Foundation for Medical Research
- Paul F. Glenn Laboratories for the Biological Mechanisms of Aging
### Conflicts of Interest
- D.A. Sinclair is a consultant to and inventor on patents licensed to Sirtris/GSK

## Replication Status
Core SIRT1 activation mechanism replicated; some metabolic effects contested in human studies

## References
- Howitz KT et al. Nature. 2003;425(6954):191-196. PMID: 12939617
- Baur JA et al. Nature. 2006;444(7117):337-342. PMID: 17086191
- Lagouge M et al. Cell. 2006;127(6):1109-1122. PMID: 17112576

## Source Data
- **Source System:** PubMed
- **Last Modified in Source:** 2025-01-22